Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

875 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bioprosthetic Pulmonary Valve Dysfunction in Congenital Heart Disease.
Patel PM, Zapata D, Qu W, Callahan M, Rao N, Kelleman M, Kanter KR, Chai PJ, Shaw FR, Shashidharan S, Rosenblum JM. Patel PM, et al. Among authors: callahan m. Ann Thorac Surg. 2023 Mar;115(3):641-648. doi: 10.1016/j.athoracsur.2021.12.025. Epub 2022 Jan 11. Ann Thorac Surg. 2023. PMID: 35031286
Mitochondrial protective potential of fucoxanthin in brain disorders.
Ferdous KA, Jansen J, Amjad E, Pray E, Bloch R, Benoit A, Callahan M, Park HA. Ferdous KA, et al. Among authors: callahan m. J Nutr Sci. 2024 Jul 25;13:e21. doi: 10.1017/jns.2024.16. eCollection 2024. J Nutr Sci. 2024. PMID: 39776519 Free PMC article. Review.
Contrast Media in Children: Ten Important Concepts on Administration, Applications, Complications, and Environmental Considerations, From the AJR Special Series on Contrast Media.
Forbes-Amrhein MM, Chow JS, Horst KK, Kim HH, Krishnamurthy R, Maloney E, McDonald RJ, Scheller LG, Stein D, Callahan MJ. Forbes-Amrhein MM, et al. Among authors: callahan mj. AJR Am J Roentgenol. 2024 Nov 27. doi: 10.2214/AJR.24.32009. Online ahead of print. AJR Am J Roentgenol. 2024. PMID: 39602099 Review.
Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).
Powell MA, Cibula D, O'Malley DM, Boere I, Shahin MS, Savarese A, Chase DM, Gilbert L, Black D, Herrstedt J, Sharma S, Kommoss S, Gold MA, Thijs AM, Ring K, Bolling MF, Buscema J, Gill SE, Nowicki P, Nevadunsky N, Callahan M, Willmott L, McCourt C, Billingsley C, Ghamande SA, He Z, Balas MM, Stevens S, Fleming E, Mirza MR. Powell MA, et al. Among authors: callahan m. Gynecol Oncol. 2025 Jan;192:40-49. doi: 10.1016/j.ygyno.2024.10.022. Epub 2024 Nov 12. Gynecol Oncol. 2025. PMID: 39531903 Clinical Trial.
Pooled Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone in Patients With Advanced Melanoma.
Long GV, Larkin J, Schadendorf D, Grob JJ, Lao CD, Márquez-Rodas I, Wagstaff J, Lebbé C, Pigozzo J, Robert C, Ascierto PA, Atkinson V, Postow MA, Atkins MB, Sznol M, Callahan MK, Topalian SL, Sosman JA, Kotapati S, Thakkar PK, Ritchings C, Pe Benito M, Re S, Soleymani S, Hodi FS. Long GV, et al. Among authors: callahan mk. J Clin Oncol. 2024 Nov 6:JCO2400400. doi: 10.1200/JCO.24.00400. Online ahead of print. J Clin Oncol. 2024. PMID: 39504507
875 results